Delivery Order SPE2DB22D1017-SPE2DB25FE9FP

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,030.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,115,953 units of the prescription medication droxidopa 100 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 5, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award is for the delivery of 100 mg capsules of the prescription drug droxidopa, with a ceiling value of $5,160.66 and a completion date of June 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is a delivery order placed under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,796 units of Droxidopa 300 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and a ceiling value of $30,036.24, with a performance period extending until May 6, 2025. The contract is not set aside for any specific...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,555.09, is for the delivery of 4567678075 ! DROXIDOPA 100 MG CAPSULE 90S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,586.62 firm fixed-price contract is for the delivery of 4,564,640,389 units of the drug Droxidopa 100 mg capsules. The contract has a completion date of May 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6MVR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200 mg Droxidopa capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $22,532.79 and a performance period through April 30, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,091,994 units of the prescription medication Droxidopa 100 mg capsules in 90-count packages. The contract has a ceiling value of $5,948.85 and a period of performance ending on May 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $6,776.80, is a delivery order placed by the Defense Logistics Agency (DLA) to supply 4,564,666,798 units of the prescription medication droxidopa 200 mg capsule in quantities of 90s. The award has no set-aside designation and is a firm fixed-price contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY8J9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,008.41 firm fixed-price delivery order contract is for the supply of 4566929688 - DROXIDOPA 300 MG CAPSULE 90S. The ultimate completion date for this contract is January 15, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
This federal contract award, identified as SPE2DB25D3018|SPE2DB25FUXMP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,236,364 units of DROXIDOPA 300 MG CAPSULE 90S, a medication, with a ceiling value of $28,310.61. The contract is a firm fixed-price arrangement with a period of performance extending to May 14, 2025. Amerisourcebergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9FP
    Delivery Order

This federal contract award, valued at $7,207.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of droxidopa 100 mg capsules, a medication used to treat certain neurological conditions.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:17 PM